S
GSK icon

SignatureFD’s GSK GSK Stock Holding History

SignatureFD’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,080
Closed -$1K – 1281
2015
Q2 		$1K Buy
4,080
+80
+2% +$4.5K ﹤0.01% 961
2015
Q1 		$7K Hold
4,000
– – ﹤0.01% 599
2014
Q4 		$4K Buy
4,000
+2,800
+233% +$157K ﹤0.01% 660
2014
Q3 		$1K Buy
+1,200
New +$73.6K ﹤0.01% 635

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SignatureFD's GSK Position: Q2 2026 in Review

SignatureFD increased its GSK (GSK) stake by 4.8% in Q2 2026, buying an estimated $118K and bringing the position to 48,502 shares worth $2.54M. The position accounts for 0.03% of the portfolio, ranked #210.

SignatureFD first reported a position in GSK in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.55M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SignatureFD held 48,502 shares of GSK worth $2.54M as of Q2 2026.
  • SignatureFD bought 2,237 GSK shares in Q2 2026, an estimated $118K.
  • GSK made up 0.03% of SignatureFD's portfolio in Q2 2026, its #210 holding.
  • SignatureFD first reported a position in GSK in Q2 2013 and has held it in 50 quarters since.
  • SignatureFD's GSK position peaked at $2.55M in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.